{"id":19105,"date":"2014-04-09T10:29:59","date_gmt":"2014-04-09T14:29:59","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=19105"},"modified":"2014-04-09T11:27:20","modified_gmt":"2014-04-09T15:27:20","slug":"technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105","title":{"rendered":"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/09\/2014 (wallstreetpr) &#8211;<b>\u00a0Puma Biotechnology Inc. (NYSE:PBYI)<\/b> is currently above its 200 day moving average which is currently at $75.98. The momentum indicators for the stocks are indicating further bearishness, and we might see lower levels. We would suggest traders to go short only if the 200 day moving average is breached for targets of $60 in the short term and keeping a stop loss just above the 200 day moving average at $78.Positional traders can short the stock at current levels for targets of $70.86 and if the level of $70.86 is broken we can easily see levels of $65.<\/p>\n<p style=\"text-align: justify;\">\u00a0<b>Cornerstone On Demand, Inc. (NASDAQ:CSOD)<\/b><b>\u00a0<\/b><\/p>\n<p style=\"text-align: justify;\"><b>Cornerstone On Demand, Inc. (NASDAQ:CSOD)<\/b> has seen a massive amount of selling in the past few sessions which have resulted in the stock being dragged below both its 50 day and 200 day moving averages. We believe that the stock can see some amount of pull back as the momentum indicator and the relative strength index for the stock are in oversold territories, and short term traders can buy the stock at current levels with a stop loss placed at $38 for targets of $42-$43 in the short term.<\/p>\n<p style=\"text-align: justify;\">\u00a0<b>Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)<\/b><\/p>\n<p style=\"text-align: justify;\"><b>Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)<\/b> has seen a massive down tick in the past few trading sessions, and we believe that this downward trajectory might continue for the stock and may lead it to lower levels. Short term traders can short the stock at current levels with a tight stop loss at $11 for targets of $8 or lower. Positional traders can also take short positions in the stock as we believe that the stock can head lower to levels of $6 and $5 in the medium term, and they should maintain a tight stop loss of $11 on a weekly closing basis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/09\/2014 (wallstreetpr) &#8211;\u00a0Puma Biotechnology Inc. (NYSE:PBYI) is currently above its 200 day moving average which is currently at $75.98. The momentum indicators for [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":19107,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264,263],"tags":[5964,5966,5965,5967,5963,5962],"stock_ticker":[],"class_list":["post-19105","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","category-technology","tag-cornerstone-on-demand-inc-nasdaqcsod","tag-galmed-pharmaceuticals-ltd-nasdaqglmd","tag-nasdaqcsod","tag-nasdaqglmd","tag-nysepbyi","tag-puma-biotechnology-inc-nysepbyi","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/09\/2014 (wallstreetpr) &#8211;\u00a0Puma Biotechnology Inc. (NYSE:PBYI) is currently above its 200 day moving average which is currently at $75.98. The momentum indicators for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-09T14:29:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-04-09T15:27:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"365\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)\",\"datePublished\":\"2014-04-09T14:29:59+00:00\",\"dateModified\":\"2014-04-09T15:27:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\"},\"wordCount\":309,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg\",\"keywords\":[\"Cornerstone On Demand Inc. (NASDAQ:CSOD)\",\"Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)\",\"NASDAQ:CSOD\",\"NASDAQ:GLMD\",\"NYSE:PBYI\",\"Puma Biotechnology Inc. (NYSE:PBYI)\"],\"articleSection\":[\"Business\",\"Health\",\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\",\"name\":\"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg\",\"datePublished\":\"2014-04-09T14:29:59+00:00\",\"dateModified\":\"2014-04-09T15:27:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg\",\"width\":1024,\"height\":365},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105","og_locale":"en_US","og_type":"article","og_title":"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) - Wall Street PR","og_description":"Boston, MA 04\/09\/2014 (wallstreetpr) &#8211;\u00a0Puma Biotechnology Inc. (NYSE:PBYI) is currently above its 200 day moving average which is currently at $75.98. The momentum indicators for [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-04-09T14:29:59+00:00","article_modified_time":"2014-04-09T15:27:20+00:00","og_image":[{"width":1024,"height":365,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)","datePublished":"2014-04-09T14:29:59+00:00","dateModified":"2014-04-09T15:27:20+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105"},"wordCount":309,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg","keywords":["Cornerstone On Demand Inc. (NASDAQ:CSOD)","Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)","NASDAQ:CSOD","NASDAQ:GLMD","NYSE:PBYI","Puma Biotechnology Inc. (NYSE:PBYI)"],"articleSection":["Business","Health","Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105","url":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105","name":"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg","datePublished":"2014-04-09T14:29:59+00:00","dateModified":"2014-04-09T15:27:20+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/puma-biotechnology.jpg","width":1024,"height":365},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/technical-bytes-puma-biotechnology-inc-nysepbyi-cornerstone-on-demand-inc-nasdaqcsod-galmed-pharmaceuticals-ltd-nasdaqglmd-19105#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Technical Bytes: Puma Biotechnology Inc. (NYSE:PBYI), Cornerstone On Demand, Inc. (NASDAQ:CSOD), Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/19105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=19105"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/19105\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/19107"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=19105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=19105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=19105"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=19105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}